Join us on August 24th from 1:00pm – 2:00pm ET for a webinar titled, “Clinical Pharmacology 101: How to Form a Clinical Pharmacology Strategy for Your NDA or BLA.” Nuventra’s founder, Geoffrey Banks, Ph.D., will lead the session.
All drug or biologic programs must address clinical pharmacology to enable an approvable NDA or BLA. Understanding basic clinical pharmacology strategies such as which investigations you need or don’t need and which investigations to do now versus later is important for your program’s overall strategy. Join us to learn more about developing a clinical pharmacology strategy for your NDA or BLA.
At the end of this webinar, attendees should have a better understanding of:
- Approaches to designing a clinical pharmacology program
- How to build a clinical pharmacology program
- Common mistakes and lessons learned
- Hypothetical examples of clinical pharmacology program
This event is free of charge.
Meet the Presenter
Geoffrey Banks, Ph.D., founded Nuventra in 2008 and led the company as both its CEO and as a principal consultant for more than 13 years prior to the Acquisition of Nuventra by CATO SMS. Dr. Banks has over 20 years of extensive experience in large pharma, biotechnology, and specialty pharma and an established track record of clinical, regulatory, and entrepreneurial success within the pharmaceutical industry.